E-Mail
IMAGE: A broad coalition that includes UC San Diego scientists sets commitments for field trials of powerful gene drive technology. The multidisciplinary group encourages trials that are safe, transparent and ethical. view more
Credit: Stephanie Gamez, UC San Diego
The modern rise of gene drive research, accelerated by CRISPR-Cas9 gene editing technology, has led to transformational waves rippling across science.
Gene drive organisms (GDOs), developed with select traits that are genetically engineered to spread through a population, have the power to dramatically alter the way society develops solutions to a range of daunting health and environmental challenges, from controlling dengue fever and malaria to protecting crops against plant pests.
Share this article
ALBUQUERQUE, N.M., Dec. 15, 2020 /PRNewswire/
The Foundation for the National Institutes of Health (NIH) has recently published on their website (Home | FNIH) a summary workshop on experience with animal models of COVID-19 (SARS-CoV-2). The work was performed as part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program, which is a public-private partnership aimed at prioritizing and speeding development of the most promising COVID-19 vaccines and treatments. The workshop evaluated and presented on best practices in virology, assays, and various species of animal models that are being used in the fight against COVID-19.
Lovelace Biomedical Scientist Dr. Adam Werts presented on the use of the Syrian Hamster to evaluate treatments and vaccines against the virus. The use of animal models to help advance therapeutics against this life threatening disease has been apparent during this pandemic. The science has moved faste